Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

1.

Giving legs to restless legs: a case study of how the media helps make people sick.

Woloshin S, Schwartz LM.

PLoS Med. 2006 Apr;3(4):e170. Epub 2006 Apr 11. Review. No abstract available.

2.

[Ropinirole in the treatment of restless legs].

Hellebek A, Kampmann JP.

Ugeskr Laeger. 2005 Jun 6;167(23):2541; author reply 2541-2. Danish. No abstract available.

PMID:
16008015
3.

Ropinirole (Requip) for restless legs syndrome.

[No authors listed]

Med Lett Drugs Ther. 2005 Aug 1;47(1214):62-4. No abstract available.

PMID:
16052162
4.

Ropinirole in restless leg syndrome.

Ahmed I.

Mo Med. 2002 Sep-Oct;99(9):500-1.

PMID:
12462942
5.

Ropinirole treatment for restless legs syndrome.

Chitnis S.

Expert Opin Drug Metab Toxicol. 2008 May;4(5):655-64. doi: 10.1517/17425255.4.5.655 . Review.

PMID:
18484922
6.

Ropinirole treatment for restless legs syndrome.

Molnar MZ, Fornadi K, Shapiro CM.

Drugs Today (Barc). 2006 Sep;42(9):587-98. Review.

PMID:
17028668
7.

Response to ropinirole in restless legs syndrome is independent of baseline serum ferritin.

Morgan JC, Ames M, Sethi KD.

J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):964-5. doi: 10.1136/jnnp.2008.147397. No abstract available.

PMID:
18645218
8.

[Impulse control disorder induced by the use of dopamine agonists].

Weber WE, Nijssen PC.

Ned Tijdschr Geneeskd. 2009 Jan 17;153(3):80-1. Dutch. No abstract available.

PMID:
19235343
9.

Punding in patients on dopamine agonists for restless leg syndrome.

Evans AH, Stegeman JR.

Mov Disord. 2009 Jan 15;24(1):140-1. doi: 10.1002/mds.22309. No abstract available.

PMID:
18855926
10.

Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.

Bayard S, Langenier MC, Dauvilliers Y.

Sleep. 2013 Oct 1;36(10):1501-7. doi: 10.5665/sleep.3044.

11.

Opioid-induced hyperalgesia and dopamine-induced augmentation in an intractable and refractory case of RLS.

Chokroverty S.

Sleep Med. 2015 Oct;16(10):1304. doi: 10.1016/j.sleep.2015.08.005. Epub 2015 Aug 18. No abstract available.

PMID:
26386895
12.

Psychosis related to ropinirole.

Perea E, Robbins BV, Hutto B.

Am J Psychiatry. 2006 Mar;163(3):547-8. No abstract available.

PMID:
16513886
13.

Ropinirole for restless legs syndrome.

Ondo W.

Mov Disord. 1999 Jan;14(1):138-40.

PMID:
9918357
14.

Restless leg syndrome, dopamine agonists and sleep attacks.

Rose AR, Antic NA, McEvoy RD.

Intern Med J. 2008 Nov;38(11):872-3. doi: 10.1111/j.1445-5994.2008.01816.x. No abstract available.

PMID:
19120542
15.

Ropinirole for restless legs syndrome: a placebo-controlled crossover trial.

Adler CH, Hauser RA, Sethi K, Caviness JN, Marlor L, Anderson WM, Hentz JG.

Neurology. 2004 Apr 27;62(8):1405-7.

PMID:
15111683
16.

Drug quiets restless legs syndrome.

[No authors listed]

Health News. 2004 Dec;10(12):2. No abstract available.

PMID:
15645558
17.

Restless legs symptoms in a patient with above knee amputations: a case of phantom restless legs.

Hanna PA, Kumar S, Walters AS.

Clin Neuropharmacol. 2004 Mar-Apr;27(2):87-9.

PMID:
15252270
18.

Sleep attacks in patients receiving dopamine-receptor agonists.

Plowman BK, Boggie DT, Morreale AP, Schaefer MG, Delattre ML, Chan H.

Am J Health Syst Pharm. 2005 Mar 1;62(5):537-40. Review. No abstract available.

PMID:
15745920
19.

Use of ropinirole in RLS.

Dobson AM, Cuellar N.

Nurse Pract. 2006 Dec;31(12):46-8. Review. No abstract available.

PMID:
17149136
20.

[Dopamine agonists for treatment of restless leg syndrome].

[No authors listed]

Med Monatsschr Pharm. 2006 Aug;29(8):313-4. German. No abstract available.

PMID:
16927607

Supplemental Content

Support Center